Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply
- PMID: 36516100
- PMCID: PMC11323957
- DOI: 10.1056/NEJMc2212542
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply
Conflict of interest statement
Since publication of their article, the authors report no further potential conflict of interest.
Comment on
-
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.N Engl J Med. 2022 Aug 18;387(7):599-610. doi: 10.1056/NEJMoa2201662. N Engl J Med. 2022. PMID: 36070710 Free PMC article. Clinical Trial.
-
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.N Engl J Med. 2022 Dec 15;387(24):e65. doi: 10.1056/NEJMc2212542. N Engl J Med. 2022. PMID: 36516099 No abstract available.
References
-
- Pocock SJ, Stone GW. The primary outcome fails — what next? N Engl J Med 2016;375:861–70. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources